Charles Schwab Investment Management Inc Anixa Biosciences Inc Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 12,785 shares of ANIX stock, worth $38,866. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,785
Previous 12,785
-0.0%
Holding current value
$38,866
Previous $40,000
22.5%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ANIX
# of Institutions
62Shares Held
5.73MCall Options Held
7.1KPut Options Held
26.7K-
Vanguard Group Inc Valley Forge, PA1.39MShares$4.23 Million0.0% of portfolio
-
D.A. Davidson & Co.671KShares$2.04 Million0.01% of portfolio
-
Laird Norton Trust Company, LLC622KShares$1.89 Million0.21% of portfolio
-
Ubs Group Ag534KShares$1.62 Million0.0% of portfolio
-
Mission Wealth Management, LP470KShares$1.43 Million0.03% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $93.2M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...